Role of the promoter polymorphism IL-6 -174G/C in dermatomyositis and systemic lupus erythematosus

BioMed Research International

Volumn 2013, Issue , 2013, Pages

  Hristova, Maria ^a   Dourmishev, Lyubomir ^a   Kamenarska, Zornitsa ^a   Nikolova, Svetla ^a   Kaneva, Radka ^a   Vinkov, Anton ^b   Baleva, Marta ^a   Monova, Daniela ^c   Mitev, Vanio ^a  

^a MEDICAL UNIVERSITY OF SOFIA   (Bulgaria)

^b Medical Diagnostics and Consulting Center 28   (Bulgaria)

^c MINISTRY OF THE INTERIOR   (Bulgaria)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 6;

ADULT; ARTHRITIS; ARTICLE; CONTROLLED STUDY; DERMATOMYOSITIS; FEMALE; GENE EXPRESSION; GENETIC SUSCEPTIBILITY; GENOTYPING TECHNIQUE; HEMATOLOGIC DISEASE; HUMAN; IMMUNOPATHOLOGY; IN VITRO STUDY; IN VIVO STUDY; INFLAMMATION; KIDNEY DISEASE; MAJOR CLINICAL STUDY; MALE; MOUTH ULCER; MUSCLE WEAKNESS; NEUROLOGIC DISEASE; PHOTOSENSITIVITY; PROMOTER REGION; RASH; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; SINGLE NUCLEOTIDE POLYMORPHISM; SYSTEMIC LUPUS ERYTHEMATOSUS; CASE CONTROL STUDY; GENETIC ASSOCIATION; GENETICS; GENOTYPE; MIDDLE AGED; PATHOLOGY; SEXUAL DEVELOPMENT;

ADULT; CASE-CONTROL STUDIES; DERMATOMYOSITIS; FEMALE; GENETIC ASSOCIATION STUDIES; GENOTYPE; HUMANS; INTERLEUKIN-6; LUPUS ERYTHEMATOSUS, SYSTEMIC; MALE; MIDDLE AGED; POLYMORPHISM, RESTRICTION FRAGMENT LENGTH; POLYMORPHISM, SINGLE NUCLEOTIDE; PROMOTER REGIONS, GENETIC; SEX CHARACTERISTICS;

EID: 84884858842     PISSN: 23146133     EISSN: 23146141     Source Type: Journal    
DOI: 10.1155/2013/315365     Document Type: Article

References (29)

1. O'Shea J. J., Ma A., Lipsky P., Cytokines and autoimmunity. Nature Reviews Immunology 2002 2 1 37 45 2-s2.0-0036359580 (Pubitemid 37328774)
2. Pawlik A., Baskiewicz-Masiuk M., Machalinski B., Gawronska-Szklarz B., Association of cytokine gene polymorphisms and the release of cytokines from peripheral blood mononuclear cells treated with methotrexate and dexamethasone. International Immunopharmacology 2006 6 3 351 357 2-s2.0-31044452490 10.1016/j.intimp.2005.08.019 (Pubitemid 43120449)
3. Dourmishev L., Kamenarska Z., Hristova M., Dodova R., Kaneva R., Mitev V., Association of TNF-α polymorphisms with adult dermatomyositis and systemic lupus erythematosus in Bulgarian patients. International Journal of Dermatology 2012 51 12 1467 1473 10.1111/j.1365-4632.2012.05522.x
4. Linker-Israeli M., Wallace D. J., Prehn J., Michael D., Honda M., Taylor K. D., Paul-Labrador M., Fischel-Ghodsian N., Fraser P. A., Klinenberg J. R., Association of IL-6 gene alleles with systemic lupus erythematosus (SLE) and with elevated IL-6 expression. Genes and Immunity 1999 1 1 45 52 2-s2.0-0033188315 (Pubitemid 129622780)
5. Sabry A., Sheashaa H. A., El-Husseini A., Mahmoud K., Eldahshan K. F., George S. K., Abdel-Khalek E., El-Shafey E. M., Abo-Zenah H., Proinflammatory cytokines (TNF-α and IL-6) in Egyptian patients with SLE: Its correlation with disease activity. Cytokine 2006 35 3-4 148 153 2-s2.0-33750516949 10.1016/j.cyto.2006.07.023 (Pubitemid 44666430)
6. Sabry A., Elbasyouni S. R., Sheashaa H. A., Alhusseini A. A., Mahmoud K., George S. K., Kaleek E. A., Abo-Zena H., Kalil A. M., Mohsen T., Rahim M. A., El-Samanody A. Z., Correlation between levels of TNF-alpha; and IL-6 and hematological involvement in SLE Egyptian Patients with lupus nephritis. International Urology and Nephrology 2006 38 3-4 731 737 2-s2.0-33847395836 10.1007/s11255-006-0047-9 (Pubitemid 46336033)
7. Langen R. C. J., Schols A. M. W. J., Kelders M. C. J. M., van der Velden J. L. J., Wouters E. F. M., Janssen-Heininger Y. M. W., Tumor necrosis factor-α inhibits myogenesis through redox-dependent and -independent pathways. American Journal of Physiology 2002 283 3 C714 C721 2-s2.0-0036720492 (Pubitemid 34920304)
8. Hagiwara E., Adams E. M., Plotz P. H., Klinman D. M., Abnormal numbers of cytokine producing cells in patients with polymyositis and dermatomyositis. Clinical and Experimental Rheumatology 1996 14 5 485 491 2-s2.0-0029812789 (Pubitemid 26335471)
9. Bilgic H., Ytterberg S. R., Amin S., McNallan K. T., Wilson J. C., Koeuth T., Ellingson S., Newman B., Bauer J. W., Peterson E. J., Baechler E. C., Reed A. M., Interleukin-6 and type I interferon-regulated genes and chemokines Mark disease activity in dermatomyositis. Arthritis and Rheumatism 2009 60 11 3436 3446 2-s2.0-70350523961 10.1002/art.24936
10. Fishman D., Faulds G., Jeffey R., Mohamed-Ali V., Yudkin J. S., Humphries S., Woo P., The effect of novel polymorphisms in the interleukin-6 (IL-6) gene on IL-6 transcription and plasma IL-6 levels, and an association with systemic- onset juvenile chronic arthritis. The Journal of Clinical Investigation 1998 102 7 1369 1376 2-s2.0-0032189103 (Pubitemid 28467565)
11. Humphries S. E., Luong L. A., Ogg M. S., Hawe E., Miller G. J., The interleukin-6 -174G/C promoter polymorphism is associated with risk of coronary heart disease and systolic blood pressure in healthy men. European Heart Journal 2001 22 24 2243 2252 2-s2.0-0035661847 10.1053/euhj.2001.2678 (Pubitemid 34000979)
12. Hulkkonen J., Pertovaara M., Antonen J., Pasternack A., Hurme M., Elevated interleukin-6 plasma levels are regulated by the promoter region polymorphism of the IL6 gene in primary Sjögren's syndrome and correlate with the clinical manifestations of the disease. Rheumatology 2001 40 6 656 661 2-s2.0-0034938412
13. Sfrent-Cornateanu R., Mihai C., Balan S., Ionescu R., Moldoveanu E., The IL-6 promoter polymorphism is associated with disease activity and disability in systemic sclerosis. Journal of Cellular and Molecular Medicine 2006 10 4 955 959 2-s2.0-34548164402
14. Sawczenko A., Azooz O., Paraszczuk J., Idestrom M., Croft N. M., Savage M. O., Ballinger A. B., Sanderson I. R., Intestinal inflammation-induced growth retardation acts through IL-6 in rats and depends on the -174 IL-6 G/C polymorphism in children. Proceedings of the National Academy of Sciences of the United States of America 2005 102 37 13260 13265 2-s2.0-24944439793 10.1073/pnas.0503589102 (Pubitemid 41325011)
15. di Renzo L., Bianchi A., Saraceno R., Calabrese V., Cornelius C., Iacopino L., Chimenti S., de Lorenzo A., -174G/C IL-6 gene promoter polymorphism predicts therapeutic response to TNF-α blockers. Pharmacogenetics and Genomics 2012 22 2 134 142
16. Bohan A., Peter J. B., Polymyositis and dermatomyositis I. The New England Journal of Medicine 1975 292 7 344 347 2-s2.0-0016850495
17. Bohan A., Peter J. B., Polymyositis and dermatomyositis II. The New England Journal of Medicine 1975 292 8 403 407 2-s2.0-0016638734
18. Targoff I. N., Miller F. W., Medsger T. A. Jr., Oddis C. V., Classification criteria for the idiopathic inflammatory myopathies. Current Opinion in Rheumatology 1997 9 6 527 535 2-s2.0-0030867050 (Pubitemid 27504210)
19. Libra M., Signorelli S. S., Bevelacqua Y., Navolanic P. M., Bevelacqua V., Polesel J., Talamini R., Stivala F., Mazzarino M. C., Malaponte G., Analysis of G(-174)C IL-6 polymorphism and plasma concentrations of inflammatory markers in patients with type 2 diabetes and peripheral arterial disease. Journal of Clinical Pathology 2006 59 2 211 215 2-s2.0-32544459783 10.1136/jcp.2004.025452 (Pubitemid 43235590)
20. Hamdy E., Afify R. A., Kamal A., Abass D., Mahmoud M., IL-6 promoter polymorphism (-174G/C) and systemic lupus erythematosus. Comperative Clinical Pathology 2012 21 5 975 979 10.1007/s00580-011-1211-x
21. Chua K. H., Kee B. P., Tan S. Y., Lian L. H., Interleukin-6 promoter polymorphisms (-174G/C) in Malaysian patients with systemic lupus erythematosus. Brazilian Journal of Medical and Biological Research 2009 42 6 551 555 2-s2.0-68149170951
22. Schotte H., Schlüter B., Rust S., Assmann G., Domschke W., Gaubitz M., Interleukin-6 promoter polymorphism (-174G/C) in Caucasian German patients with systemic lupus erythematosus. Rheumatology 2001 40 4 393 400 2-s2.0-0035041157
23. Santos M. J., Fernandes D., Capela S., da Silva J. C., Fonseca J. E., Interleukin-6 promoter polymorphism -174G/C is associated with nephritis in Portuguese Caucasian systemic lupus erythematosus patients. Clinical Rheumatology 2011 30 3 409 413 2-s2.0-79954593760 10.1007/s10067-010-1640-y
24. Huang C.-M., Huo A.-P., Tsai C.-H., Chen C.-L., Tsai F.-J., Lack of association of interleukin-6 and interleukin-8 gene polymorphisms in Chinese patients with systemic lupus erythematosus. Journal of Clinical Laboratory Analysis 2006 20 6 255 259 2-s2.0-33845273119 10.1002/jcla.20151 (Pubitemid 44865239)
25. Borinskaya S. A., Gureev A. S., Orlova A. A., Allele frequency distributions of -174G/C polymorphism in regulatory region of interleukin 6 gene (IL6) in Russian and worldwide populations. Russian Journal of Genetics 2013 49 1 98 109 10.1134/S1022795413010031
26. Lee Y. H., Lee H. S., Choi S. J., Ji J. D., Song G. G., The association between interleukin-6 polymorphisms and systemic lupus erythematosus: a meta-analysis. Lupus 2012 21 1 60 67 2-s2.0-83655164152 10.1177/0961203311422711
27. Godarzi E. M., Sarvestani E. K., Aflaki E., Amirghofran Z., Interleukin-6 gene polymorphism in Iranian patients with systemic lupus erythematosus. Clinical Rheumatology 2011 30 2 179 184 2-s2.0-79954446639 10.1007/s10067-010- 1452-0
28. Schaap L. A., Pluijm S. M. F., Deeg D. J. H., Visser M., Inflammatory markers and loss of muscle mass (sarcopenia) and strength. The American Journal of Medicine 2006 119 6 526.e9 526.e17 2-s2.0-33646902419 10.1016/j.amjmed.2005. 10.049 (Pubitemid 43795180)
29. Haddad F., Zaldivar F., Cooper D. M., Adams G. R., IL-6-induced skeletal muscle atrophy. Journal of Applied Physiology 2005 98 3 911 917 2-s2.0-14144252542 10.1152/japplphysiol.01026.2004 (Pubitemid 40283672)